Metal Springs Market
Spring is a simple object which stores mechanical energy and can be twisted, pulled, or stretched ... Read More
Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market - Global Outlook and Forecast 2024-2031
1 Introduction to Research & Analysis Reports
1.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Overall Market Size
2.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size: 2021 VS 2028
2.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players in Global Market
3.2 Top Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Companies Ranked by Revenue
3.3 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players in Global Market
3.6.1 List of Global Tier 1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Markets, 2021 & 2028
4.1.2 Delafloxacin
4.1.3 Vancomycin
4.1.4 Ceftaroline Fosamil
4.1.5 Others
4.2 By Type - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue & Forecasts
4.2.1 By Type - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, 2017-2022
4.2.2 By Type - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, 2023-2028
4.2.3 By Type - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2021 & 2028
5.1.2 Cellulitis
5.1.3 Abscess
5.1.4 Surgical Wounds
5.1.5 Traumatic Wound
5.2 By Application - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue & Forecasts
5.2.1 By Application - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, 2017-2022
5.2.2 By Application - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, 2023-2028
5.2.3 By Application - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2021 & 2028
6.2 By Region - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue & Forecasts
6.2.1 By Region - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, 2017-2022
6.2.2 By Region - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, 2023-2028
6.2.3 By Region - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, 2017-2028
6.3.2 US Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.3.3 Canada Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.3.4 Mexico Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, 2017-2028
6.4.2 Germany Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.4.3 France Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.4.4 U.K. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.4.5 Italy Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.4.6 Russia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.4.8 Benelux Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, 2017-2028
6.5.2 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.5.3 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.5.4 South Korea Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.5.6 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, 2017-2028
6.6.2 Brazil Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.6.3 Argentina Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, 2017-2028
6.7.2 Turkey Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.7.3 Israel Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
6.7.5 UAE Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Furiex Pharmaceuticals, Inc.
7.1.1 Furiex Pharmaceuticals, Inc. Corporate Summary
7.1.2 Furiex Pharmaceuticals, Inc. Business Overview
7.1.3 Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.1.4 Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.1.5 Furiex Pharmaceuticals, Inc. Key News
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Corporate Summary
7.2.2 GlaxoSmithKline plc Business Overview
7.2.3 GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.2.4 GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.2.5 GlaxoSmithKline plc Key News
7.3 Melinta Therapeutics, Inc.
7.3.1 Melinta Therapeutics, Inc. Corporate Summary
7.3.2 Melinta Therapeutics, Inc. Business Overview
7.3.3 Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.3.4 Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.3.5 Melinta Therapeutics, Inc. Key News
7.4 Debiopharm International S.A.
7.4.1 Debiopharm International S.A. Corporate Summary
7.4.2 Debiopharm International S.A. Business Overview
7.4.3 Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.4.4 Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.4.5 Debiopharm International S.A. Key News
7.5 MerLion Pharmaceuticals Pte Ltd.
7.5.1 MerLion Pharmaceuticals Pte Ltd. Corporate Summary
7.5.2 MerLion Pharmaceuticals Pte Ltd. Business Overview
7.5.3 MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.5.4 MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.5.5 MerLion Pharmaceuticals Pte Ltd. Key News
7.6 Durata Therapeutics, Inc.
7.6.1 Durata Therapeutics, Inc. Corporate Summary
7.6.2 Durata Therapeutics, Inc. Business Overview
7.6.3 Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.6.4 Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.6.5 Durata Therapeutics, Inc. Key News
7.7 Paratek Pharmaceuticals, Inc.
7.7.1 Paratek Pharmaceuticals, Inc. Corporate Summary
7.7.2 Paratek Pharmaceuticals, Inc. Business Overview
7.7.3 Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.7.4 Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.7.5 Paratek Pharmaceuticals, Inc. Key News
7.8 Cempra, Inc.
7.8.1 Cempra, Inc. Corporate Summary
7.8.2 Cempra, Inc. Business Overview
7.8.3 Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.8.4 Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.8.5 Cempra, Inc. Key News
7.9 Abbott Laboratories, Inc.
7.9.1 Abbott Laboratories, Inc. Corporate Summary
7.9.2 Abbott Laboratories, Inc. Business Overview
7.9.3 Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.9.4 Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.9.5 Abbott Laboratories, Inc. Key News
7.10 Actelion Pharmaceuticals Ltd.
7.10.1 Actelion Pharmaceuticals Ltd. Corporate Summary
7.10.2 Actelion Pharmaceuticals Ltd. Business Overview
7.10.3 Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.10.4 Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.10.5 Actelion Pharmaceuticals Ltd. Key News
7.11 Albany Molecular Research, Inc.
7.11.1 Albany Molecular Research, Inc. Corporate Summary
7.11.2 Albany Molecular Research, Inc. Business Overview
7.11.3 Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.11.4 Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.11.5 Albany Molecular Research, Inc. Key News
7.12 Allergan plc.
7.12.1 Allergan plc. Corporate Summary
7.12.2 Allergan plc. Business Overview
7.12.3 Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.12.4 Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.12.5 Allergan plc. Key News
7.13 AstraZeneca
7.13.1 AstraZeneca Corporate Summary
7.13.2 AstraZeneca Business Overview
7.13.3 AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.13.4 AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.13.5 AstraZeneca Key News
7.14 Bayer AG
7.14.1 Bayer AG Corporate Summary
7.14.2 Bayer AG Business Overview
7.14.3 Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.14.4 Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.14.5 Bayer AG Key News
7.15 Macrolide Pharmaceuticals, Inc.
7.15.1 Macrolide Pharmaceuticals, Inc. Corporate Summary
7.15.2 Macrolide Pharmaceuticals, Inc. Business Overview
7.15.3 Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.15.4 Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.15.5 Macrolide Pharmaceuticals, Inc. Key News
7.16 Merck & Co, Inc.
7.16.1 Merck & Co, Inc. Corporate Summary
7.16.2 Merck & Co, Inc. Business Overview
7.16.3 Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.16.4 Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.16.5 Merck & Co, Inc. Key News
7.17 Pfizer, Inc.
7.17.1 Pfizer, Inc. Corporate Summary
7.17.2 Pfizer, Inc. Business Overview
7.17.3 Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.17.4 Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.17.5 Pfizer, Inc. Key News
7.18 Sanofi
7.18.1 Sanofi Corporate Summary
7.18.2 Sanofi Business Overview
7.18.3 Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.18.4 Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.18.5 Sanofi Key News
7.19 Teva Pharmaceuticals Industries Ltd.
7.19.1 Teva Pharmaceuticals Industries Ltd. Corporate Summary
7.19.2 Teva Pharmaceuticals Industries Ltd. Business Overview
7.19.3 Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.19.4 Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.19.5 Teva Pharmaceuticals Industries Ltd. Key News
7.20 Zavante Therapeutics, Inc.
7.20.1 Zavante Therapeutics, Inc. Corporate Summary
7.20.2 Zavante Therapeutics, Inc. Business Overview
7.20.3 Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Major Product Offerings
7.20.4 Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global Market (2017-2022)
7.20.5 Zavante Therapeutics, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Opportunities & Trends in Global Market
Table 2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Drivers in Global Market
Table 3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Restraints in Global Market
Table 4. Key Players of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment in Global Market
Table 5. Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Type
Table 9. List of Global Tier 1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Furiex Pharmaceuticals, Inc. Corporate Summary
Table 31. Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 32. Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline plc Corporate Summary
Table 34. GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 35. GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Melinta Therapeutics, Inc. Corporate Summary
Table 37. Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 38. Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Debiopharm International S.A. Corporate Summary
Table 40. Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 41. Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 42. MerLion Pharmaceuticals Pte Ltd. Corporate Summary
Table 43. MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 44. MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Durata Therapeutics, Inc. Corporate Summary
Table 46. Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 47. Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Paratek Pharmaceuticals, Inc. Corporate Summary
Table 49. Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 50. Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Cempra, Inc. Corporate Summary
Table 52. Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 53. Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Abbott Laboratories, Inc. Corporate Summary
Table 55. Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 56. Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Actelion Pharmaceuticals Ltd. Corporate Summary
Table 58. Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 59. Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Albany Molecular Research, Inc. Corporate Summary
Table 61. Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 62. Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Allergan plc. Corporate Summary
Table 64. Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 65. Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 66. AstraZeneca Corporate Summary
Table 67. AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 68. AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Bayer AG Corporate Summary
Table 70. Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 71. Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Macrolide Pharmaceuticals, Inc. Corporate Summary
Table 73. Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 74. Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Merck & Co, Inc. Corporate Summary
Table 76. Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 77. Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 78. Pfizer, Inc. Corporate Summary
Table 79. Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 80. Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 81. Sanofi Corporate Summary
Table 82. Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 83. Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 84. Teva Pharmaceuticals Industries Ltd. Corporate Summary
Table 85. Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 86. Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
Table 87. Zavante Therapeutics, Inc. Corporate Summary
Table 88. Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Offerings
Table 89. Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Segment by Type in 2021
Figure 2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Segment by Application in 2021
Figure 3. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in 2021
Figure 8. By Type - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share, 2017-2028
Figure 12. US Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share, 2017-2028
Figure 24. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
114